South & Central America Arterial Blood Gas Kits Market Forecast to 2031 - Regional Analysis - by Syringe Type, Type, Usage, Application, Needle Gauge, Syringe Volume, and End User

The South & Central America arterial blood gas kits market was valued at US$ 30.27 million in 2023 and is expected to reach US$ 51.04 million by 2031; it is estimated to register a CAGR of 6.7% from 2023 to 2031.

Surging Adoption of Point-of-Care Diagnostics in Emerging Countries Fuels South & Central America Arterial Blood Gas Kits Market

The inability to run rapid diagnoses is a significant cause of deaths resulting from various diseases in emerging countries. An effective diagnostic infrastructure requires stable electrical power, sophisticated instruments, expensive reagents, and highly trained professionals; thus, diagnoses in developing countries are often limited by the unavailability of these resources. Moreover, the existing diagnostic capabilities result in long assay times, rendering them unsuitable for settings with limited resource availability. Point-of-care testing offers immediate diagnostic results at or near the patient's location, enabling rapid clinical decision-making, streamlined workflows, and enhanced patient outcomes. The need for timely interventions, efficient diagnostic processes, and personalized healthcare delivery fuels the demand for decentralized testing solutions. Point-of-care arterial blood gas kits allow healthcare providers to perform critical diagnostic tests at the patient's bedside, in emergency departments, or in remote settings, facilitating on-the-spot assessment of blood gas parameters, electrolyte levels, and acid-base status. The accessibility and immediacy of point-of-care analyzers empower clinicians to promptly initiate appropriate treatments, monitor patient responses in real time, and optimize clinical decision-making in acute care scenarios. The shift toward point-of-care diagnostics also drives technological advancements in arterial blood gas kits as manufacturers focus on developing compact, automated, and easy-to-use devices that deliver accurate and fast results. The seamless integration of point-of-care analyzers into healthcare workflows enhances operational efficiency, reduces turnaround times for results, and improves the overall quality of patient care. Thus, as healthcare settings embrace the advantages of point-of-care testing, the demand for portable and user-friendly arterial blood gas kits is rising in developing countries, which is likely to create growth opportunities for the market in the coming years.

South & Central America Arterial Blood Gas Kits Market Overview

As per the study titled “Prevalence of people at risk of developing type 2 diabetes and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil,” published in 2020, Brazil is one of the top 10 countries across the world in terms of the total number of diabetes cases recorded every year. The International Diabetes Federation (IDF) Diabetes Atlas 2021 estimated that 15.7 million people aged 20-79 years have diabetes in Brazil. The number is expected to reach 23.2 million by 2045. Blood gas and electrolyte analyzers can detect acid-base imbalances that can cause metabolic diseases such as diabetes. According to the data from the Pan American Health Organization (PAHO), Brazil had over 30 million people aged 60 years and above in 2022, representing 13% of the country's population. By 2030, the number of cases is expected to reach ~50 million, representing 24% of the total populace. As per the Brazil Statistical Institute, the country’s population aged 65 and above is expected to hold a 36% share of the total population by 2050. A majority of the geriatric population in the country suffers from asthma and COPD. An upsurge in the geriatric population across the country, coupled with the increasing prevalence of chronic disorders such as kidney conditions, respiratory disorders, and diabetes, is likely to create lucrative opportunities for the arterial blood gas kits market growth during the forecast period.

South & Central America Arterial Blood Gas Kits Market Segmentation

The South & Central America arterial blood gas kits market is categorized into syringe type, type, usage, application, needle gauge, syringe volume, end user, and country.

Based on syringe type, the South & Central America arterial blood gas kits market is bifurcated into luer slip syringe and luer lock syringe. The luer lock syringe segment held a larger market share in 2023.

In terms of type, the South & Central America arterial blood gas kits market is bifurcated into vented and non-vented. The vented segment held a larger market share in 2023.

By usage, the South & Central America arterial blood gas kits market is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger market share in 2023.

Based on application, the South & Central America arterial blood gas kits market is bifurcated into in vitro diagnostics and electrolyte analysis. The in vitro diagnostics segment held a larger market share in 2023. Furthermore, the in vitro diagnostics segment is sub segmented into pH blood gas, oxygen content, and others.

In terms of needle gauge, the South & Central America arterial blood gas kits market is segmented into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held the largest market share in 2023.

Based on syringe volume, the South & Central America arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3ml segment held the largest market share in 2023.

By end user, the South & Central America arterial blood gas kits market is categorized into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics held the largest market share in 2023.

Based on country, the South & Central America arterial blood gas kits market is segmented into Brazil, Argentina, Colombia, and the Rest of South & Central America. Brazil dominated the South & Central America arterial blood gas kits market share in 2023.

Radiometer Medical ApS, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC (AirLife), SARSTEDT AG & Co KG, and Lepu Medical Technology Beijing Co Ltd. are among the leading companies operating in the South & Central America arterial blood gas kits market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America arterial blood gas kits market.
• Highlights key business priorities to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the South & Central America arterial blood gas kits market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America arterial blood gas kits market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.